Concerns about the safety of Acadia Pharmaceuticals Inc.'s (Nasdaq: ACAD) Nuplazid sent shares of the biopharmaceutical plummeting $5.03 to close at $16.50.
Safety concerns sink Acadia Pharmaceuticals
April 09, 2018 at 19:08 PM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.